The FDA approved Adstiladrin, the first gene therapy to treat high-risk, non-muscle-invasive bladder cancer, Dec. 16.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves 1st gene therapy for bladder cancer
The FDA approved Adstiladrin, the first gene therapy to treat high-risk, non-muscle-invasive bladder cancer, Dec. 16.
Read the full post on Becker's Hospital Review - Healthcare News